Abstract
Moxalactam (LY127935), a novel beta-lactam antibiotic, was compared with semisynthetic penicillins, cephalosporins, and aminoglycosides by the agar dilution method against 5,317 recent clinical isolates of facultative and anaerobic bactria. At 0.5 μg/ml, moxalactam inhibited 90% of all Gram-negative bacilli tested except forPseudomonas aeruginosa (81% inhibited by 32 μg/ml) andAcinetobacter calcoaceticus (88% inhibited by 32 μg/ml). More than 90% ofBacteroides fragilis andStaphylococcus aureus were inhibited by 4 μg/ml and 8 μg/ml, respectively. Moxalactam was at least 16-fold more active by weight than cephalothin, cefamandole, and cefoxitin forEscherichia coli, Klebsiella pneumoniae, andEnterobacter species, and 2- to 4-fold more active than cefoxitin forB. fragilis. Moxalactam was 4-fold less active than cefamandole and cephalothin forS. aureus and 2- to 4-fold less active than piperacillin forP. aeruginosa. Moxalactam was as active or more active than the aminoglycosides for all facultative Gram-negative bacilli except forP. aeruginosa. Moxalactam was inhibitory (minimal inhibitory concentration <16 μg/ml) for 20/27 gentamicin-resistant isolates and 8/13 amikacin-resistant organisms. Moxalactam’s in vitro activity against Gram-negative bacilli is markedly superior to presently available cephalosporins and, except forP. aeruginosa, is comparable to the aminoglycosides.
Similar content being viewed by others
Literature Cited
Dhawan, V., Marso, E., Martin, W. J., Young, L. S. 1977. In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrobial Agents and Chemotherapy11:64–73.
Ericsson, H. M., Sherris, J. C. 1971. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathologica et Microbiologica Scandinavica, Sect. B., Suppl.217:90.
Ewing, W. H., Martin, W. J. 1974. Enterobacteriaceae, pp. 189–221. In: Lennette, E. H., Spaulding, E. H., Truant, J. P., (eds.), Manual of clinical microbiology, 2nd ed. Washington, D. C.: American Society for Microbiology.
Fass, R. J. 1979. In vitro activity of LY127935. Antimicrobial Agents and Chemotherapy16:503–509.
Hugh, R., Gilardi, G. L. 1974. pseudomonas, pp. 250–269. In: Lennette, E. H., Spaulding, E. H., Truant, J. P. (eds.), Manual of clinical microbiology, 2nd ed. Washington, D. C.: American Society for Microbiology.
Sabath, L. D., McCall, C. E., Steigbigel, N. H., Finland, M. 1966. Synergistic penicillin combinations for treatment of human urinary-tract infections, pp. 149–155. In: Antimicrobial Agents and Chemotherapy. Ann Arbor, Michigan: American Society for Microbiology.
Sutter, V. L., Attebery, H. R., Finegold, S. M. 1974. Gramnegative nonsporeforming anaerobic bacilli, pp 388–395. In: Lennette, E. H., Spaulding, E. H., Truant, J. P. (eds.), Manual of clinical microbiology, 2nd ed. Washington, D. C.: American Society for Microbiology.
Tatum, H. W., Ewing, W. H., Weaver, R. E. 1974. Miscellaneous gram-negative bacteria, pp. 270–294. In: Lennette, E. H., Spaulding, E. H., Truant, J. P. (eds.), Manual of clinical microbiology, 2nd ed. Washington, D. C.: American Society for Microbiology.
Washington, J. A., Barry, A. L. 1974. Dilution test procedures, pp. 410–417. In: Lennette, E. H., Spaulding, E. H., Truant, J. P. (eds.), Manual of clinical microbiology, 2nd ed. Washington, D. C.: American Society for Microbiology.
Weaver, S. S., LeBlanc, B. M., Bodey, G. P. 1980. In vitro studies of l-oxacephalosporin (LY127935), a new beta-lactam antibiotic. Antimicrobial Agents and Chemotherapy17:92–95.
Weinstein, R. J., Young, L. S., Hewitt, W. L. 1975. Comparison of methods for assessing in vitro antibiotic synergism againstPseudomonas andSerratia. Journal of Laboratory and Clinical Medicine86:853–862.
Wilkins, T. D., Chalgren, S. 1976. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrobial Agents and Chemotherapy10:926–928.
Young, L. S., Hewitt, W. L. 1973. Activity of five aminoglycoside antibiotics in vitro against Gram-negative bacilli andStaphylococcus aureus. Antimicrobial Agents and Chemotherapy4:617–625.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurtz, T.O., Winston, D.J., Martin, W.J. et al. Comparative in vitro activity of moxalactam (LY127935), other beta-lactam antibiotics, and aminoglycosides. Current Microbiology 4, 21–26 (1980). https://doi.org/10.1007/BF02602886
Issue Date:
DOI: https://doi.org/10.1007/BF02602886